Follow the 아이센스 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 아이센스 has published 73 reports. The latest transaction was reported on 30 June 2026 (Other). Among the most active insiders: 이상주. All data is openly available.
72
Insider Decl.
n/a
Thresholds
€9,993
29 ops.
Buy Volume
n/a
22 ops.
Sell Volume
22Σ signal
Buys €9,993n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
아이센스 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative technologies and solutions for the medical field.